Enovis CEO Talks Tech, ASCs and Strategic Focus

Enovis is an innovative medtech company that generated more than $535 million in Reconstructive segment sales in 2022. The company ultimately resulted from the 2018 acquisition of DJO by Colfax. Since then, CEO Matt Trerotola has led a company that's able to take significant market share and seamlessly enter attractive adjacencies.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us